Fundz

Eleven Therapeutics Announces $22 Million In Seed Funding

PRIVATEAug 02, 2022

Amount Raised

$22 Million

Round Type

Seed

Tel AvivBiotechnologyHealth CareArtificial IntelligenceTherapeuticsMarket Research

Description

Eleven Therapeutics, a biotechnology company leading the AI revolution in nucleic acid therapeutics, announced today that it has raised a total of $22 million in seed funding.

Quick answer

Eleven Therapeutics raised $22 Million in a Seed round, dated August 2, 2022. Eleven Therapeutics is based in Tel Aviv, Tel Aviv District, Israel.

How much did Eleven Therapeutics raise?
Eleven Therapeutics raised $22 Million in a Seed round on August 2, 2022.
What does Eleven Therapeutics do?
Eleven Therapeutics ushers in the next generation of RNAi therapeutics by combining artificial intelligence (AI), massively parallel functional assays, and combinatorial chemistry.
Where is Eleven Therapeutics based and how big is it?
Eleven Therapeutics is based in Tel Aviv, Tel Aviv District, Israel.
Who are the decision-makers at Eleven Therapeutics?
Fundz holds 1 contact at Eleven Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Market Research around the same time

Companies in the same sectors as Eleven Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Differentiated Therapeutics raised $5M (Seed) on August 1, 2022.
  • Novome raised an undisclosed amount (Funding Round) on September 15, 2022.
  • Carver raised an undisclosed amount (Seed) on September 15, 2022.
  • Adaptive Biotechnologies Corporation raised an undisclosed amount (Grant) on September 12, 2022.
  • Photys Therapeutics raised $75M (Series A) on September 8, 2022.
  • Autobahn Therapeutics raised an undisclosed amount (Funding Round) on September 8, 2022.

Who to call at Eleven Therapeutics, and when

A new round usually means Eleven Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Eleven Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eleven Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eleven Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eleven Therapeutics

Location

Tel Aviv, Tel Aviv District, Israel

About

Eleven Therapeutics ushers in the next generation of RNAi therapeutics by combining artificial intelligence (AI), massively parallel functional assays, and combinatorial chemistry. Its flagship invention features a new modality, dubbed SCSI-RNATM (smart-combinatorial, small interfering RNA), a fully programmable molecule, rationally designed to address the delivery, durability, and efficacy challenges of any disease and biological target of interest. Founded in 2020 by a group of globally-leading, interdisciplinary scientists, Eleven Therapeutics brings new RNAi therapeutics for patients in need by capitalising on some of the world's best pools of talent through its three collaborative hubs—in Cambridge, UK; Boston, U.S.; and Tel Aviv, Israel. Eleven is currently focusing its development pipeline on siRNA treatments for a range of respiratory diseases. To learn more, visit www.eleventx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eleven Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Eleven Therapeutics's next move

See what Strategic adds

Eleven Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.